AzTrials
AzTrials

Type 2 Diabetes MellitusI-ACENCT01858506

Diabetes Lifestyle Assessment and Educational Tools

A study testing I-ACE intervention and Standard Lifestyle Advice in people with Type 2 Diabetes Mellitus, run by Ofra Kalter-Leibovici MD at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim: To evaluate a culturally-adapted method of lifestyle assessment, counseling, and education among Arab people with diabetes who have varying literacy skills using an interactive computerized tool and graphically-enhanced patient logs for dietary and physical activity. Read more about this study

Who is it for?
Ages 40 to 64 years
Conditions the study is for
Type 2 Diabetes Mellitus
What is being tested?
I-ACE intervention and Standard Lifestyle Advice
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteIsrael
Study dates
Aug 2014to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 64 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 40-64 years old
  • BMI 27-45 kg/m2
  • Diagnosis of type 2 diabetes mellitus in medical record
  • HbA1c 8.0%-11.5%

Who cannot join

  • Short-acting insulin treatment
  • Inadequate control of co-morbid conditions
  • Factors that may limit adherence to interventions (e.g., any medical or physical condition that limits the ability to participate in physical activity or standard diets recommended for people with diabetes, pregnancy, uncontrolled psychiatric condition, significant cognitive impairment, blindness).

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Clalit Health Services, Shomron administration

    Hadera

Other trials in Israel

About this study

Official title: Development and Evaluation of Lifestyle Assessment and Educational Tools for Diabetic People With Limited Literacy

Aim: To evaluate a culturally-adapted method of lifestyle assessment, counseling, and education among Arab people with diabetes who have varying literacy skills using an interactive computerized tool and graphically-enhanced patient logs for dietary and physical activity.

The investigators hypothesize that this tool will: a) increase patients' knowledge and understanding of the role of lifestyle (diet and physical activity) in diabetes management; b) improve patients' engagement in monitoring dietary intake and physical activity; c) improve dietary and physical activity behaviors and self-blood glucose monitoring (SBGM) practices; d) improve glycemic control; and, e) improve the efficiency of lifestyle assessment, education and counseling while increasing patients' engagement in the process.

Read the detailed description

Aim: To evaluate a culturally-adapted method of lifestyle assessment, counseling, and education among Arab people with diabetes who have varying literacy skills using an interactive computerized tool and graphically-enhanced patient logs for dietary and physical activity. The investigators will evaluate the effectiveness of this method for: a) increasing patients' knowledge and understanding of the role of lifestyle (diet and physical activity) in diabetes management; b) improving patients' engagement in monitoring dietary intake and physical activity; c) improving dietary and physical activity behaviors and self-blood glucose monitoring (SBGM) practices; d) improving glycaemic control; and, e) improving the efficiency of lifestyle assessment, education and counseling while increasing patients' engagement in the process.

Being tested
I-ACE intervention, Standard Lifestyle Advice
Keywords
Type 2 diabetes mellitus, Lifestyle counselling, Lifestyle assessment, Randomized controlled trial, Diabetes education
Medical subject headings
Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • I-ACE interventionProcedure or surgery

    lifestyle counselling using the interactive assessment, counselling and education (I-ACE)-based method.

  • Standard Lifestyle AdviceProcedure or surgery

    lifestyle counselling using the standard lifestyle advice (SLA) program currently provided to Clalit Health Services patients.

Study groups in NCT01858506
Study groupRoleWhat they receive
I-ACE intervention armExperimentallifestyle counselling using the interactive assessment, counselling and education (I-ACE)-based method.
Receives: Procedure: I-ACE intervention
Standard lifestyle advice armActive comparatorlifestyle counselling using the standard lifestyle advice (SLA) program currently provided to Clalit Health Services patients.
Receives: Procedure: Standard Lifestyle Advice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in lifestyle knowledge

    Change in diabetes-related lifestyle (diet and physical activity) knowledge, will be assessed with a diet knowledge questionnaire specially adapted for this population. Change in physical activity knowledge will be measured with the SKILLD diabetes knowledge questionnaire.

    Measured: Baseline, 3rd,6th,12th months

Secondary outcomes (5)
  1. Patients' lifestyle monitoring

    Patient engagement in monitoring diet intake and physical activity, assessed with 3-day dietary and physical activity records.

    Measured: 1st,2nd,3rd,6th months

  2. Dietary and physical activity behaviours

    Dietary and physical activity behaviours, assessed with food frequency and physical activity questionnaires.

    Measured: Baseline and 12 months.

  3. SBGM practices

    Self Blood Glucose Monitoring practices. Information will be downloaded from the blood glucose meters' memory.

    Measured: 1st, 2nd, 3rd, 6th, 12th months.

  4. Glycaemic control

    Glycaemic control, assessed with HbA1c levels.

    Measured: Baseline, 3rd,6th, and 12th months.

  5. Weight and waist circumference

    Change of weight and waist circumference during follow-up.

    Measured: Baseline, 3rd, 6th, and 12th months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 May 2013 (estimated)
  2. Study startAug 2014
  3. Primary completionFeb 2016
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01858506
Sponsor's protocol ID
EFSD_I-ACE
Other IDs
8677-11-SMC
Acronym
I-ACE
Status last verified
Apr 2016
First submitted
12 May 2013
Last updated
15 Apr 2016
Results posted
No
Data monitoring committee
No

Publications

  • Abu-Saad K, Murad H, Barid R, Olmer L, Ziv A, Younis-Zeidan N, Kaufman-Shriqui V, Gillon-Keren M, Rigler S, Berchenko Y, Kalter-Leibovici O. Development and Efficacy of an Electronic, Culturally Adapted Lifestyle Counseling Tool for Improving Diabetes-Related Dietary Knowledge: Randomized Controlled Trial Among Ethnic Minority Adults With Type 2 Diabetes Mellitus. J Med Internet Res. 2019 Oct 16;21(10):e13674. doi: 10.2196/13674.

    PubMed 31621640

Questions about this trial

What is this clinical trial studying?

A study testing I-ACE intervention and Standard Lifestyle Advice in people with Type 2 Diabetes Mellitus, run by Ofra Kalter-Leibovici MD at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in lifestyle knowledge (time frame: Baseline, 3rd,6th,12th months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01858506, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in